Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Crespi

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 29, 1999
Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profilesP Roy, L J Yu, C L Crespi, et al.
Carcinogenesis|July 1, 1991
A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6C L Crespi, B W Penman, H V Gelboin, et al.
Cancer Research|December 1, 1993
Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomesT K Chang, G F Weber, C L Crespi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 21, 2000
Analysis of drug transport and metabolism in cell monolayer systems that have been modified by cytochrome P4503A4 cDNA-expressionC L Crespi, L Fox, P Stocker, et al.
Carcinogenesis|February 1, 1989
Transfection of a human cytochrome P-450 gene into the human lymphoblastoid cell line, AHH-1, and use of the recombinant cell line in gene mutation assaysC L Crespi, R Langenbach, K Rudo, et al.
Carcinogenesis|May 1, 1989
Development of a human cell line by selection and drug-metabolizing gene transfection with increased capacity to activate promutagensR L Davies, C L Crespi, K Rudo, et al.
Mutation Research|March 17, 1997
Mutagenicity of the atmospheric transformation products 2-nitrofluoranthene and 2-nitrodibenzopyranone in Salmonella and human cell forward mutation assaysW F Busby, H Smith, C L Crespi, et al.
Annals of the New York Academy of Sciences|November 18, 2000
Fluorometric high-throughput screening for inhibitors of cytochrome P450V P Miller, D M Stresser, A P Blanchard, et al.
Molecular Carcinogenesis|January 1, 1990
Stable expression of human cytochrome P450IA2 cDNA in a human lymphoblastoid cell line: role of the enzyme in the metabolic activation of aflatoxin B1C L Crespi, D T Steimel, T Aoyama, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 29, 1999
Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cellsD L Lanza, E Code, C L Crespi, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 29, 1999
Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profilesP Roy, L J Yu, C L Crespi, et al.
Carcinogenesis|July 1, 1991
A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6C L Crespi, B W Penman, H V Gelboin, et al.
Cancer Research|December 1, 1993
Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomesT K Chang, G F Weber, C L Crespi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 21, 2000
Analysis of drug transport and metabolism in cell monolayer systems that have been modified by cytochrome P4503A4 cDNA-expressionC L Crespi, L Fox, P Stocker, et al.
Carcinogenesis|February 1, 1989
Transfection of a human cytochrome P-450 gene into the human lymphoblastoid cell line, AHH-1, and use of the recombinant cell line in gene mutation assaysC L Crespi, R Langenbach, K Rudo, et al.
Carcinogenesis|May 1, 1989
Development of a human cell line by selection and drug-metabolizing gene transfection with increased capacity to activate promutagensR L Davies, C L Crespi, K Rudo, et al.
Mutation Research|March 17, 1997
Mutagenicity of the atmospheric transformation products 2-nitrofluoranthene and 2-nitrodibenzopyranone in Salmonella and human cell forward mutation assaysW F Busby, H Smith, C L Crespi, et al.
Annals of the New York Academy of Sciences|November 18, 2000
Fluorometric high-throughput screening for inhibitors of cytochrome P450V P Miller, D M Stresser, A P Blanchard, et al.
Molecular Carcinogenesis|January 1, 1990
Stable expression of human cytochrome P450IA2 cDNA in a human lymphoblastoid cell line: role of the enzyme in the metabolic activation of aflatoxin B1C L Crespi, D T Steimel, T Aoyama, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 29, 1999
Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cellsD L Lanza, E Code, C L Crespi, et al.
Pageof 10